BioNexus Gene Lab (BGLC) Competitors $5.36 -0.21 (-3.77%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$5.44 +0.09 (+1.59%) As of 08/14/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BGLC vs. KDLY, BMGL, CCM, MRAI, BRTX, MGRX, SSY, DHAC, ACON, and ATIPShould you be buying BioNexus Gene Lab stock or one of its competitors? The main competitors of BioNexus Gene Lab include Kindly MD (KDLY), Basel Medical Group (BMGL), Concord Medical Services (CCM), Marpai (MRAI), Biorestorative Therapies (BRTX), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Digital Health Acquisition (DHAC), Aclarion (ACON), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry. BioNexus Gene Lab vs. Its Competitors Kindly MD Basel Medical Group Concord Medical Services Marpai Biorestorative Therapies Mangoceuticals SunLink Health Systems Digital Health Acquisition Aclarion ATI Physical Therapy BioNexus Gene Lab (NASDAQ:BGLC) and Kindly MD (NASDAQ:KDLY) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk. Which has stronger valuation and earnings, BGLC or KDLY? BioNexus Gene Lab has higher revenue and earnings than Kindly MD. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioNexus Gene Lab$9.51M1.01-$1.60MN/AN/AKindly MD$2.47M32.30-$4.64M-$0.77-17.21 Is BGLC or KDLY more profitable? Kindly MD has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -22.85%. Kindly MD's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets BioNexus Gene Lab-22.85% -24.18% -20.14% Kindly MD N/A N/A N/A Do insiders & institutionals hold more shares of BGLC or KDLY? 18.9% of BioNexus Gene Lab shares are held by institutional investors. 0.7% of BioNexus Gene Lab shares are held by insiders. Comparatively, 50.5% of Kindly MD shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media prefer BGLC or KDLY? In the previous week, BioNexus Gene Lab had 2 more articles in the media than Kindly MD. MarketBeat recorded 2 mentions for BioNexus Gene Lab and 0 mentions for Kindly MD. Kindly MD's average media sentiment score of 1.10 beat BioNexus Gene Lab's score of 0.43 indicating that Kindly MD is being referred to more favorably in the news media. Company Overall Sentiment BioNexus Gene Lab Neutral Kindly MD Positive SummaryKindly MD beats BioNexus Gene Lab on 6 of the 10 factors compared between the two stocks. Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BGLC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGLC vs. The Competition Export to ExcelMetricBioNexus Gene LabMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.01M$7.54B$5.62B$9.84BDividend YieldN/A2.71%4.61%4.07%P/E RatioN/A72.1630.2925.74Price / Sales1.0129.89463.41115.83Price / CashN/A26.7338.2159.48Price / Book1.1618.428.826.15Net Income-$1.60M$243.10M$3.25B$265.06M7 Day Performance-3.77%2.82%3.71%2.60%1 Month Performance42.93%2.66%5.85%2.83%1 Year Performance19.19%20.03%29.92%25.58% BioNexus Gene Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGLCBioNexus Gene Lab0.157 of 5 stars$5.36-3.8%N/A+21.3%$10.01M$9.51M0.0030Short Interest ↑KDLYKindly MDN/A$7.58+19.4%N/A+720.4%$45.65M$2.47M-9.84N/ANews CoveragePositive NewsGap UpBMGLBasel Medical GroupN/A$2.05-0.5%N/AN/A$38.02MN/A0.0036CCMConcord Medical Services0.4794 of 5 stars$5.05-5.4%N/A-33.9%$23.18M$52.60M0.00970Negative NewsShort Interest ↑Gap DownMRAIMarpaiN/A$1.34-0.7%N/A+122.6%$22.33M$34.87M-0.51150News CoverageGap UpBRTXBiorestorative Therapies2.5457 of 5 stars$1.49+0.7%$18.00+1,108.1%+7.1%$11.11M$400K-1.017Earnings ReportAnalyst RevisionMGRXMangoceuticals0.689 of 5 stars$1.77+1.1%N/A-97.9%$9.05M$620K-0.383Positive NewsEarnings ReportShort Interest ↑SSYSunLink Health Systems2.4034 of 5 stars$1.02-8.9%N/A+41.8%$7.18M$31.09M7.291,376Short Interest ↓Gap UpHigh Trading VolumeDHACDigital Health AcquisitionN/A$1.39+14.9%N/A-53.9%$5.01MN/A0.002,021Gap DownHigh Trading VolumeACONAclarion1.7728 of 5 stars$7.40+5.7%$11,758.50+158,798.6%-99.6%$4.08M$50K0.007Earnings ReportGap UpATIPATI Physical TherapyN/A$0.68flatN/A-88.9%$2.98M$741.86M-0.045,600 Related Companies and Tools Related Companies KDLY Alternatives BMGL Alternatives CCM Alternatives MRAI Alternatives BRTX Alternatives MGRX Alternatives SSY Alternatives DHAC Alternatives ACON Alternatives ATIP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGLC) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access